Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I read MedCity because it captures the pulse of what's going on in healthcare innovation, a go to source. I also like how MedCity supports women in digital health.”

Dr. Charlene Ngamwajasat, @doctorcharlene, Physician and techie


Sign up for our daily newsletter


St. Jude Medical layoffs affect 300 as it centralizes functions, realigns into two units

August 30, 2012 2:48 pm by | 0 Comments

2011 Medtronic layoffs MDT NYSE:MDT

St. Jude Medical (NYSE:STJ)  announced Thursday that it is laying of 300 employees as part of a broader restructuring aimed to lower operating costs.

In a news release, the Minnesota medical device maker said that it is centralizing support functions in information technology, human resources, legal, business development and many marketing functions. The job cuts are expected to reduce pretax operational expenses by $50 million to $60 million per year.

Eighty of the total eliminated positions were in Minnesota, said a St. Jude Medical spokeswoman via email.

Along with the layoffs, the company is also reorganizing its business into two operating units — Implantable Electronic Systems Division (IESD), which will combine the company’s cardiac rhythm management business and the neuromodulation business; and the Cardiovascular and Ablation Technologies Division, which will comprise the atrial fibrillation business and the cardiovascular division.

“The reorganization we have announced today is part of a comprehensive plan to accelerate our growth,” said Daniel Starks, chairman, president and chief executive officer of St. Jude Medical. “We are focused on reducing costs, leveraging economies of scale, maintaining the highest level of quality and funding our entire portfolio of new growth drivers.”

The newly formed IESD will be led by Eric Fain, the former president of the cardiac rhythm management business. Meanwhile, Frank Callaghan, the former head of the Cardiovascular Division will lead the Cardiovascular and Ablation Technologies Division. The two executives will report to group President Michael Rousseau.

Four other executives are also seeing their roles change. Donald Zurbay now becomes chief financial officer and vice president, finance. He replaces John Heinmiler, who is taking on the task of executive vice president as he supervises the centralization of the HR, IT, legal and business development functions. Rachel Ellingson has been named vice president of corporate relations while Angela Craig will assume additional responsibilities as vice president of global human resources.

A newly created role of vice president, global regulatory will be fulfilled by Kathleen Chester.

 

 

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Arundhati Parmar

By Arundhati Parmar

Arundhati Parmar is the Medical Devices Reporter at MedCity News. She has covered medical technology since 2008 and specialized in business journalism since 2001. Parmar has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.
More posts by Author

0 comments